Engagement with healthcare providers (HCPs) is critical for market success. How to effectively engage is shifting, including the use of hybrid, data-driven sales calls and AI. The use of Contract Sales Organizations is also on the rise, with an approach that expands the pipeline of potential prescribers and offers biopharma companies a faster, more flexible commercial model that reduces risk, controls costs and scales resources. This playbook explores how Contract Sales Organizations can help biopharma companies identify and activate underrepresented HCP segments. Unlock new growth opportunities while improving the relevance and value of your HCP engagement. Highlights include: The limitations in traditional HCP targeting and the role of pharma sales reps. Identifying and activating underrepresented HCP segments—and how AI is often overlooked. The role of Contract Sales Organizations in enabling pharma companies to gain rapid entry into emerging markets.
